| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO | EVP, R&D &CMO
2 companies
O'Neill Gilmore Neil is a CEO at Editas Medicine, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 9 sells.
Estimated insider holdings value: $1.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 3, 2025 | EDIT Editas Medicine, Inc. | CEO | Sell | 5,603 | $2.15 | $12,063.82 | -2.0% | -13.7% | - | |
| Sep 3, 2025 | EDIT Editas Medicine, Inc. | CEO | Sell | 5,592 | $2.60 | $14,517.39 | -2.0% | -15.6% | - | |
| Jun 3, 2025 | EDIT Editas Medicine, Inc. | CEO | Sell | 15,192 | $1.72 | $26,195.57 | -5.1% | +35.7% | - | |
| Mar 4, 2025 | EDIT Editas Medicine, Inc. | CEO | Sell | 16,632 | $1.71 | $28,452.36 | -5.3% | +0.6% | +25.0% | |
| Dec 3, 2024 | EDIT Editas Medicine, Inc. | CEO | Sell | 1,618 | $2.08 | $3,361.23 | -0.5% | -10.6% | +19.4% | |
| Sep 4, 2024 | EDIT Editas Medicine, Inc. | CEO | Sell | 1,555 | $3.42 | $5,325.41 | -0.5% | -43.4% | -28.0% | |
| Jun 4, 2024 | EDIT Editas Medicine, Inc. | CEO | Sell | 12,191 | $5.50 | $66,996.86 | -3.7% | -39.3% | -68.3% | |
| Mar 5, 2024 | EDIT Editas Medicine, Inc. | CEO | Sell | 77,824 | $9.42 | $732,884.17 | -19.2% | -40.8% | -77.6% | |
| Jun 5, 2023 | EDIT Editas Medicine, Inc. | CEO | Sell | 6,486 | $9.50 | $61,637.76 | -4.7% | -6.5% | -39.1% |